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Summary
Information on the antigenic structure of influenza hemagglutinin (HA) has been deduced previously
from sequence analyses oflaboratory mutant viruses selected, in vitro, with neutralizing monoclonal
antibody (mAb) established exclusively from BALB/c (H-2a) mice; and there has been no attempt
to investigate the influence of host genetic background, or natural route of infection, on the
protective antibody repertoire. CBA/Ca mice are extremely sensitive to X31 virus infection, and
in the present studya structural analysis was made ofthe antibody repertoire, by direct sequencing
of the HA genes of laboratory mutant viruses selected, in ovo with mAb from CBA/Ca mice
primed by natural infection with X31 virus at two different infectious doses. Single nucleotide
substitutions in the HA genes of mutant viruses identified both novel and immunodominant
antigenic sites on the HAI subunit: a majority of mAbs, from different donors, were of the
IgG2a isotype and were specific for HAI 158 Gly. In addition, novel laboratory mutants were
obtained containing substitutions in the HAI subunit that had not been reported previously
for H3 subtype viruses, either natural variants or laboratory mutants, at residues: HAI 62 Ile
--" Arg; HAI 165 Asn --" Ser (resulting in the loss of a N-glycosylation site); and HAI 273
Pro -> Leu. Our findings suggest that host genetic background and/or a natural route of infection
may be significant factors in the selection of different and distinct neutralizing antibody responses
to influenza HA and therefore be of some relevance in our further understanding of the immune
pressure for antigenic drift, and the immunogenic features of a protective antigen.
A definitive assignment of antibody recognition sites, or
B cell epitopes of foreign proteins, requires informa-
tion on the three-dimensional structure, obtained from crys-
tallographic data for antigen-antibody complexes, whereas,
in most instances, B cell epitopes have been identified by in-
direct means such as antibody reactivity with families of
phylogenetically related proteins (e.g., myoglobin or cyto-
chrome c) (1), or by protein modification using either chem-
ical procedures or site directed mutagenesis (2). For infec-
tious pathogens that exhibit antigenic variation such as the
envelope glycoproteins of RNA viruses, a structural analysis
of mAb-selected escape mutants provides a convenient ap-
proach for identifying critical residues necessary for antibody
recognition. A primary example of this approach has been
the extensive studies undertaken with influenza haemagglu-
tinin (HA)l (3-7). Sequence analyses of the RNA genes of
mAb-selected laboratory mutants have identified single amino
acid substitutions corresponding to surface regions on the
1 Abbreviations used in thispaper. HA, hemagglutinin; HI, hemagglutination
inhibition.
membrane distal domain of the HAI subunit that have also
featured in antigenic drift (6). Analysis oflaboratory mutant
viruses therefore provides a powerful tool for correlating the
immunogenic features of a protective antigen with three-
dimensional structure, and for studies on the fine specificity
and diversity of antibody recognition.
We have found that CBA/Ca mice, in contrast to the
majority of inbred and congenic strains, are highly suscep-
tible to infection with X31 virus (H3N2 subtype; our un-
published observations) and we wished to determine whether
there was a correlation between disease susceptibility and the
neutralizing antibody repertoire to HA. We have found that
a majority oflaboratory mutant viruses, selected with a panel
of mAbs from different donors, differ from the immunizing
X31 virus by the same single amino acid substitution, HAI
158 Gly - Glu. Additional mutant viruses were character-
ized that contained novel substitutions at HAI 62 (Ile
Arg), or HAI 165 (Asn - Ser; resulting in the loss of a
N-glycosylation site) or HAI 273 (Pro -> Leu). These sub-
stitutions have not been reported previously for either nat-
ural variants or mAb (BALB/c)-selected mutant viruses of
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siderations in an analysis oftheantibody repertoire forapro-
tective antigen: first, a natural route of infection may elicit
along-lived Bmemory cell response that is restricted to fewer
and possibly different antigenic sites than obtained after im-
munization; and second, that the host genetic background
maybe asignificant determinant in the specificity of the neu-
tralizing antibody response.
Materials and Methods
Viruses.
￿
Allinfluenzaviruses were grown in the allantoic fluid
of 10-d-old embryonated eggs. The X31 virus is a recombinant
between A/Aichi/2/68 and A/PR/8/34 which expresses surface
glycoproteins oftheH3N2 subtype andPR8internal proteins (8).
Laboratory-selected mutants were obtained by mixing equalvolumes
of allantoic fluid from X31-infected embryonated eggs and ascitic
fluidcontaining anti-HA mAb. The virus/mAb mixture was left
at room temperature for 30 min and then used to inoculate em-
bryonatedeggs. Thevariants obtained were cloned, in ovo, by lim-
itingdilution and subsequently grown in large scale using on av-
erage 300 eggs per virus. The virus was purified from -2.51 of
allantoicfluidby precipitation with polyethylene glycol (5%) fol-
lowed by sucrose gradient (15-40% [wt/vol]) centrifugation.
Mice .
￿
CBA/Ca mice were bred underspecific pathogen-fleecon-
ditionsat theNational InstituteforMedicalResearch (NIMR).Mice
were infected at 3-4 mo of age.
Production ofmAb.
￿
CBA/Ca mice were infected intranasally with
either 1.5 x 10'PFU (high dose) or 2 x 106 PFU (low dose) of
X31 and boosted 6 wk later with 2 x 108 PFU administered by
intraperitoneal injection. 3 d afterboosting, splenic lymphocytes
from individual donors were fusedwith P3-X63Ag8653 myeloma
cells (9) after the fusion protocol and culture conditions described
by Fazekas de St. Groth and Scheidegger (10). Hybridomas were
screened foranti-HAactivity by hemagglutination inhibition (HI)
assay.
Hemagglutination Inhibition (HI) Assay.
￿
mAbcontaining tissue
culture medium (50 Al) was mixed with X31 virus (8HAU; 25
Al) andincubated at room temperature for30 min. 25 Al of a 2%
turkey RBC suspension was added and incubated for a further 30
min at room temperature to allow agglutination.
Table 1.
￿
Immunoglobulin Isotypes ofAnti-HA mAb
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mAbIsotypes.
￿
Theisotypes ofeach mAbused in this studywere
determined by ELISA; mAbboundto theX31 virus wasdetected
using biotinylated anti-mouse Ig isotype-specific antibodies and
a streptavidin-alkaline phosphatase conjugate.
Nucleotide Sequence Analyses oftheHA Genes of Laboratory Mu-
tantsofX31. RNAwas extracted from purified virus suspensions
(2-10mg/ml). RNAwas phenol extractedfollowed by etherwash.
Sequences were determined using the dideoxynucleotide chain-
terminating method (11) and theprocedureused hasbeen described
elsewhere (12). Briefly, -6 AM of "P-labeled primer was mixed
with 1 Ag RNA and the primer extension reaction was carried
out using individual dNTP at a finalconcentrationof 0.4 mM and
ddNTP at a concentration of 0.1 mM in a total volume of 3 pl.
The primers (kindly provided by Dr. R.S. Daniels, NIMR) were
as follows: 6-AAGCAGGGGA-15; 191TGCTACTGAGCT202;
367-GTTACCCTTATG-388; 628-ACCCGAGCACG-638; 778-
GGACAATAGT787, and numbered accordingto thesequence of
X31 hemagglutinin cDNA (13).
Results
We have found that CBA/Ca mice are highly susceptible
to intranasal infection with X31 virus (LDso <5 x 106
PFU) as compared with most otherinbred andcongenic strains
ofmice (e.g., BALB/c, BALRK, BALB.B, or B10congenics;
LDso > 2 x 107 PFU; our unpublished results). This is il-
lustrated in Fig. 1 where the weight loss (and death) after
infection of CBA/Ca and BALB/c mice has been compared.
SinceBALB/c mice do not express the autosomal dominant
MX1 gene that confers resistance to influenza(14), thediffer-
encesin susceptibility to influenza X31 infectionbetweenthese
two inbred strains of mice must therefore be under thecon-
trol of other factors. The purpose of this studywas to deter-
mine the neutralizing antibody epitopes of CBA/Ca mice
after natural infection with X31 virus.
HA-specific mAb
Novel B Cell Epitopes on Influenza Hemagglutinin
Apanel of40 anti-HA neutralizing mAbs wasderivedfrom
five CBA/Ca mice infected with X31 virus at two different
infectious doses, either 2 x 106 or 1.5 x 101 PFU, and are
Donors JCB-2, -3, -4 (high dose infection, 1.5 x 107 PFU); Donor LD4, LD6 (low dose infection, 2 x 106 PFU).
JCB-2
Clone Isotype
JcB-3
Clone Isotype
JCB-4
Clone Isotype Clone
LD4
Isotype Clone
LD6
Isotype
2B-41.1 IgG2a 3B-1 .1 IgG2a 4B-40.7 IgG3 4C4 IgG2a B72 IgG2a
-7.3.2 IgM -8.1 IgG2a -35.4 IgG2a 5D2 IgG2a C98 IgG2a
-29.1 IgG2a -4.3 IgG2b -2.1 IgG2a 6G3 IgG2a A76 IGg2b
-37.1 IgA -3.6.2 IgG2a -3 .1 IgG2a 9G12 IgG2a A122 IgG2b
-5.1.1 IgG2a -3.6 .3 ligG2a -4.3 IgGI 8D11 IgG2a D91 IgG2a
-6.1 IgG2a -5.1 IgG2b -20.1 IgG2a 3F9 IgG2a D101 IgG2b
-21.3 IgM -7.1 IgG2a -12.1 IgG1 1A12 IgG2a G63 IgG2a
-8.2 IgG2a -29.1 IgG2a 7G11 IgG2a B28 lgG2b
-6.1 IgG2a D92 IgG2aloo-,
3
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Figure 1.
￿
A comparison of thevirulenceofX31virus in CBA/Ca and
BALB/c mice as determined by body weight and survival after intranasal
infection with 107 PFU. (O) BALB/c mice; (")CBA/Ca mice + mor-
tality.
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158 189
listed in Table 1. The predominant Ig isotype among these
mAb was IgG2a. In an initial attempt to determine the level
of diversity of the secondary antibody response to HA, the
mAbs were tested by HI assay against a panel of laboratory
mutants having known single amino acid substitutions within
the HA1 subunit (Fig. 2). This panel of mutant viruses al-
lowed us to examine the effects on antibody binding of mu-
tations within four of the five antigenic sites on the HA1
subunit as defined by Wiley et al. (6). The results indicated
a high degree of diversity among the mAbs tested. For in-
stance, out of 24 mAbs generated from donors JCB-2, -3,
and -4, 15 different fine specificities were seen with respect
to their HI activity. However, it was not possible to define
precisely which amino acid residues in the HA1 subunit were
being recognized by individual antibodies. Such extensive
diversity was consistent with previous reports for the BALB/c
repertoire (15).
Site B
￿
Site D
I
￿
226 D
224-230 189 193 193 198 198 199 218 226 193
L*P
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Figure 2.
￿
A summary representation showing the complex pattern of HI reactivity of anti-HA mAb against a panel of laboratory mutant viruses
containing single amino acid substitutions within the HAI subunit and a deletion mutant, residues 224-230. (/) Inhibition of hemagglutination;
(0) partial inhibition of hemagglutination; (p) no inhibition of hemagglutination. All HI assays were performed using viruses at a concentration
of8HAU/25pl,usingtwoor more dilutionsof neutralizing mAbs andin direct comparison ofreactivity ofthemAbforwild type X31 andmutant viruses.
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Substitution
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-29.1 " 0 0Sequence Analysis of mAb-selected Laboratory Mutants
To obtain a definitive'assignment of the neutralizing anti-
body binding sites of HA1, recognized by CBA/Ca mice,
each of the above mAbs was used to select a laboratory mu-
tant of X31 virus. The HA gene of each cloned laboratory
mutant virus was sequenced and the amino acid substitution
that had occurred was deduced from the nucleotide sequence
data. Our findings are summarized in Table 2 and illustrate
novel substitutions that have, hitherto, not been reported for
either laboratory mutants or natural isolates ofthe H3 subtype.
HA1 158 (Gly --" Glu).
￿
Residue 158 occupies a position
near the tip of the HA monomer adjacent to the receptor
binding site (6) (Fig. 3). A significant finding was that the
majority of the laboratory variants differed from the wild
type X31 virus by a single substitution at this position. Com-
parison of mAbs obtained from donors infected with a low
or high dose of X31 virus showed that, in both groups, a
majority of mAbs recognized HA1 158. This restriction of
the responses was particularly striking in donorJCB-4 where
seven out of eight mAbs, o£ differing isotypes, recognized
HAI 158.
HA1 63 (Asp - Asn).
￿
This was the next most frequently
selected laboratory mutant. HAI 63 lies within antigenic site
E of the HA1 subunit (Fig. 3). This substitution introduces
an N-glycosylation site (Asn6 Cys64 Thr65) that alters the
antigenic structure of this region and abrogates both anti-
body recognition (16) and antigen presentation of an I-Ad-
restricted T cell epitope (17).
HA1 62 (Ile -.. Arg).
￿
This residue is also within anti-
genic site E and the HAI 62 Ile --+ Arg change has not been
previously reported for either laboratory mutants or natural
variant viruses of the H3 subtype. However, this same sub-
stitution has been reported for the HAs of avian H3 isolates.
HA1 165(Asn --> Ser).
￿
This residue change results in the
loss of N-glycosylation site (Asn165, Vahb6, Thr16) and has
not been reported previously for either laboratory mutants
or natural variants of the H3 subtype.
HA 273 (Pro - Leu).
￿
This residue change, occurring in
antigenic site C, has not been reported for mAb (BALB/c)-
selected laboratory mutants although natural variants of the
" HAI amino acid position.
t Laboratory mutant virus.
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Figure 3.
￿
Schematicdiagramof the three-dimensional structureof the
HAI monomerindicating residues recognized by CBA/Ca mAb (arrows)
andtheresidues that have featuredin antigenic driftofH3 subtype viruses
Table 2.
￿
The Amino Acid Substitutions (and Frequency) in Laboratory Variants Selected, In Ovo, by mAbs Derived from Individual
273
P-L
CBAICa Donors
Donor mice
62'
I--"Rt
63
D-N
129
G-"W
144
G->D
158
G-"E
165
N-S
188
N-D
JCB-2 1 1 4
JCB-3 1 2 5 1
JCB-4 1 7
LD4 2 2 2 1
LD6 2 6 1H3 subtype such as A/TEX/77 or A/BK/79 contain substi-
tutions within this region at HAI 275 (Asp --> Gly) and HAI
278 (Ile - Ser).
HA 129 (Gly - Glu).
￿
This is a radical change that has
featured in natural variants of the H3 subtype (A/QU/70
and A/HK/71) and has a profound effect on antibody binding
to the membrane distal region of HAI, as illustrated by the
failure of all mAbs specific for HAI 158 to recognize labora-
tory mutants containing this single substitution.
The other laboratory mutants obtained in this studycon-
tained single substitutions at positions HAI 144 Gly -+ Asp
and HAI 188 Asn - Asp within antigenic sites A and B
(6), represented a minor component of the CBA/Ca reper-
toire, and have been reported previously for either laboratory
mutants or natural variant viruses.
HAI 158 Gly - Glu Abrogates Antibody Binding
Since the HAI 158 Gly -" Glu change has an effect on
receptor binding (see below), it was necessary to establish
that laboratory mutants containing this substitution were in-
deed true antigenic variants. They had been screened for in
HI assays which would also detect viruses with altered receptor
affinity. Therefore, each mAb was tested by ELISA assay for
its ability to bind to the mutant virus which it selected. As
shown in Table 3, all the mutant viruses were antigenic vari-
ants as they all showed greatly reduced ability to bind the
selecting mAb as compared to X31 virus.
Table 3.
￿
Reactivity of mAb, Specific for HAI 158, with X31
Virus and the Corresponding Laboratory Mutant Viruses HAI
158 Gly --1- Glu in ELISA Assays
Titreof mAb (fromascites fluid) with X31 and with mutant virus se-
lected by the corresponding mAb.
t Titre of mAb-containing tissue culture supernatant.
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Discussion
Structural analyses of laboratory mutants of influenza,
selected in vitro with neutralizing mAb to HA, have played
a significant role in delineating the antigenically important
regions of the molecule, and for evaluating the antigenic
significance of amino acid substitutions in natural variant
viruses (3-7) . Laboratory mutant viruses differ by one, or
occasionally two, amino acid substitutions in the membrane
distal regions of the HAI subunit, and these same substi-
tutions have been identified in natural variants, thereby con-
firming their importance in antigenic drift. In all reported
studies, neutralizing mAb to HA have been obtained from
BALB/c mice, after immunization with whole virus, and
shown to be specific for one of the five major antigenic sites
of HAI. There have been no reports, however, of investiga-
tions of the antibody repertoire of other mouse strains (or
haplotypes) or the specificity of secondary responses after nat-
ural infection. In this study, an extensive analysis was made
of the neutralizing antibody repertoire of CBA/Ca mice, a
strain that is highly susceptible to X31 infection. Sequence
analyses ofthe HA genes of laboratory mutant viruses of X31
provided a structural assignment of both novel and im-
munodominant antigenic sites on the HAI subunit. Our
findings are summarized schematically on the three-dimen-
sional structure of the HA monomer (Fig. 3).
Protection against influenza infection, in vivo, correlates
with serum levels of neutralizing IgG antibodies directed
against the membrane distal region of the HAI subunit (18,
19). HI activity, the assay of choice herein for the screening
of mAb correlates with neutralizing antibody activity and
therefore provides a relevant indexof the protective antibody
repertoire ofCBA/Ca mice. Our results have shown that the
secondary antibody response is directed predominantly at HAI
158 Gly and is mainly of the IgG2a subclass. In addition,
we have described novel substitutions not previously reported
for laboratory mutants or natural variant viruses of the H3
subtype. The predominance of the IgG2aisotype in secondary
antibody response is a characteristic trait of most viral infec-
tions in the mouse (20-23) and may illustrate the influence
of antigen-specific CD4 + T cells. CD4 ' cells have been
designated as Thl or Th2 on the basis of their lymphokine
secretion profile (24): Thl cellssecrete IFN, which enhances
IgG2a synthesis in vitro (25, 26), and has been shown to
preferentially induce IgG2a production (27) . The IgG2a iso-
type does not predominate in the antibody response to im-
munization with inactivated virus (23) thus emphasizing the
role of natural infection in the selective activation ofThl cells.
HAI 158 Gly, the major antigenic site for CBA/Ca mice,
is located at the distal end of the HAI subunit adjacent to
the receptor binding site (Fig. 3). The immunodominance
of this residue did not appear to be dependent on the infec-
tious dose of virus and was most clearly illustrated by the
antibody response ofdonorJCB-4 (Table 2): in this instance,
seven out of eight mAbs recognize HAI 158, and isotype
analysis has shown that this is not an in vitro artifact, such
as repetitive sampling of a common clonotype within the
memory B cell population, since the mAbs represent several
different isotypes (IgGl; IgG2a, IgG3).
rnAb X31
Antibody titre'
X31 (158 Gly-Glu)
2B -5.1 .1 >105 <10,
-29.1 >105 <10,
-31.1 >105 <10,
3B - 6.1 105 <10'
- 8.2 102# -
- 4.3 >105 <101
- 8.1 >105 <101
- 1.1 >105 <10,
4B -12.1 1021 -
-20.1 1031 -
- 3.1 10, <10,
-40.7 104 <10'
-35.4 10, <10'
- 2.1 >105 <10'Studies with BALB/c mAbs have shown that, after im-
munization with influenza, the antibody response is directed
predominantly at a region of the HA1 monomer designated
antigenic site B (HA1 186-200; references 8, 28). Staudt and
Gerhard (15), in an extensive study on mAb-binding patterns
for a panel of H1 subtype variant viruses, estimated that the
minimum adult BALB/c repertoire consisted of 1,500 para-
topes. They also demonstrated that individual mice expressed
paratypically and idiotypically distinct repertoires. However,
these significant studies did not allow a definitive structural
assignment of antigenic sites since the diversity of antibody
reactivity did not extend to a structural analysis of mutant
HA genes. In the present study, a high degree of antibody
diversity was also evident in the HI reactivity patterns for
a panel of variant viruses (Fig. 2) and contrasted with the
limited number of antigenic changes detected at the nucleo-
tide level. This is well illustrated by the panel of mAbs de-
rived from donor JCB-4: seven of the mAbs were specific
for HAI 158, whereas HI analysis revealed five distinct pat-
terns ofreactivity. Our findings indicate that conclusions based
on HI, or antibody-binding studies alone, may indicate a de-
gree of paratypic complexity in antibody responses that are
focused on a single amino acid residue.
The receptor binding specificities ofH3 subtype influenza
viruses exhibit three distinct types, based on preferential
binding to either one or both of the sequences (sialyl 2 ->
6 gal) or (sialyl 2 --" 3 gal) that are present as terminal residues
in both O-linked (29) and N-linked (30) oligosaccharides of
membrane glycoproteins. Residue 158, although not located
within the receptor binding site, has been implicated as having
an effect on receptor binding as shown by the study of Un-
derwood et al. (31), in which it was shown that mutant viruses
with a substitution at HA1 158 had decreased affinity in
receptor binding assays using periodate-modified erythrocytes.
It was possible, therefore, that the laboratory mutants with
the HA1 158 Gly -" Glu substitution, the predominant sub-
stitution selected for by CBA/Ca mAb, were in fact receptor
binding mutants rather than antigenic variants. However, as
the selecting mAbs were unable to bind to the mutant viruses
in ELISAs, it is clear that the HA1 158 substitution affects
the antigenicity ofthe HA molecule. Interestingly, the work
of Both et al. (32) with swine influenza virus has shown that
a substitution at HA1 155 Gly --> Glu (the equivalent ofHA1
158 in the human H3 subtype) can alter the replicative ca-
Thanks to Dr. R. S. Daniels for the gift of the primers used in this study.
Fernando Temoltzin-Palacios is
y Technologia, Mexico.
pacity, or virulence of the virus. The HAI 155 Gly - Glu
change was associatedwith a 1,000-fold reduction in infectivity.
Our study has also identified laboratory mutants with single
substitutions in regions of the HA1 subunit that hitherto
have not featured in either mAb (BALB/c)-selected labora-
tory mutants or natural variants of the H3 subtype. For in-
stance, HA1 165 Asn is a N-glycosylation site (Asn165,
Val166, Thr167) that has been conserved in all natural variants
of the H3 subtype. Viruses of the H1 subtype, in contrast,
are not glycosylated at the equivalent position and do exhibit
antigenic variation in this region (7), suggesting that the car-
bohydrate moiety at HAI 165 masks the surrounding area
from immune recognition. However, the mAb-selected mu-
tant characterized in this study contains the substitution HAI
165 Asn - Ser, resulting in a loss of the consensus sequence
for N-glycosylation. A recent report has described a labora-
tory mutant with the substitution HAI 167 Thr --I- Asn,
also resulting in the loss of N-glycosylation and in changed
receptor binding properties (33). However, this was not an
antigenic variant and had been selected with # inhibitors,
which are a family ofmannose-binding lectins present in bo-
vine and murine sera. In our hands, the selecting antibody
was unable to bind to the HA1 165 mutant in ELISAs, indi-
cating that this was indeed an antigenic variant and not pro-
duced as a result ofa similar selection with (3 inhibitorspresent
in the ascitic fluid.
A further and novel laboratory mutant contained the HA1
273 Pro - Leu change. HA1 273 is within a loop region
of the HA monomer designated as antigenic site C (Fig. 3).
Although this is an antigenic region (as defined by sequence
analysis of natural variants) there has only been a single re-
port of a laboratory mutant within site C, at position HA1
53 (34). However, HA1273 has been conserved in all natural
variants so far characterized. Similarly, HA162 has been con-
served in all H3 natural isolates and has not featured in any
ofthe mAb (BALB/c)-selected laboratory mutants, hitherto
characterized.
In conclusion, the spectrum of laboratory mutant viruses
selected with mAbs from CBA/Ca mice and described herein
adds a number of different sites to those reported elsewhere
for laboratory mutant viruses selected with mAbs from
BALB/c mice (3-7) and suggests that host geneticbackground
and/or a natural route of infection may be significant factors
in eliciting a protective antibody response to influenza.
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